Stay updated on Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record presents details of a completed phase I/II study of pembrolizumab and doxorubicin for advanced sarcoma, including participation criteria, study locations, and measured outcomes. It also provides study documents and publication information.
    Difference
    58%
    Check dated 2026-11-08T10:15:47.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T11:25:55.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-25T11:45:02.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T12:14:42.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T13:48:09.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the usual study content and documents with an access-restricted message.
    Difference
    20%
    Check dated 2026-09-20T20:20:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.